Cannabinoid neuropharmacology across the lifespan: how aging recalibrates risk and benefit

NEUROPSYCHOPHARMACOLOGY · Published 2026-07-30 · DOI 10.1038/s41386-026-02511-1

Authors (2)

Gabriel P. A. Costa, Joao P. De Aquino

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Costa, G., Aquino, J. (2026). Cannabinoid neuropharmacology across the lifespan: how aging recalibrates risk and benefit. NEUROPSYCHOPHARMACOLOGY. https://doi.org/10.1038/s41386-026-02511-1

Related articles

• Proximity in mice induced by an auditory-conditioned stimulus · NEUROPSYCHOPHARMACOLOGY · 2026 · Same journal
• Psychedelics produce enduring enhancement of reward responsiveness in male rats · NEUROPSYCHOPHARMACOLOGY · 2026 · Same journal
• Dose-related reductions in prefrontal recruitment during cognitive reappraisal following oral delta-9-tetrahydrocannabinol in posttraumatic stress disorder · NEUROPSYCHOPHARMACOLOGY · 2026 · Same journal
• Repeated restraint stress enhances visual plasticity through locus coeruleus (LC)-V1 projection in adult mice · NEUROPSYCHOPHARMACOLOGY · 2026 · Same journal
• Cortisol suppression impairs retrieval of emotional memory and changes its neural correlates immediately and four days post-treatment · NEUROPSYCHOPHARMACOLOGY · 2026 · Same journal
• Persistent vulnerability to heroin relapse after more than one year of abstinence in rats · NEUROPSYCHOPHARMACOLOGY · 2026 · Same journal
• Acute and post-acute neurobehavioral responses to lysergic acid diethylamide in healthy subjects: a randomized controlled study · NEUROPSYCHOPHARMACOLOGY · 2026 · Same journal
• Splice isoforms of the histone variant macroH2A1 differentially regulate hippocampal gene expression and memory formation · NEUROPSYCHOPHARMACOLOGY · 2026 · Same journal
• The neuroanatomy of depression: weak but replicable effects in 4021 individuals from three clinical cohorts · NEUROPSYCHOPHARMACOLOGY · 2026 · Same journal
• Cannabidiol corrects sleep deficits and reduces spontaneous seizures in Angelman syndrome model mice · NEUROPSYCHOPHARMACOLOGY · 2026 · Same journal